Zella, M.A.S.; Metzdorf, J.; Ostendorf, F.; Maass, F.; Muhlack, S.; Gold, R.; Haghikia, A.; Tönges, L.
Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson’s Disease. Cells 2019, 8, 105.
https://doi.org/10.3390/cells8020105
AMA Style
Zella MAS, Metzdorf J, Ostendorf F, Maass F, Muhlack S, Gold R, Haghikia A, Tönges L.
Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson’s Disease. Cells. 2019; 8(2):105.
https://doi.org/10.3390/cells8020105
Chicago/Turabian Style
Zella, Maria Angela Samis, Judith Metzdorf, Friederike Ostendorf, Fabian Maass, Siegfried Muhlack, Ralf Gold, Aiden Haghikia, and Lars Tönges.
2019. "Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson’s Disease" Cells 8, no. 2: 105.
https://doi.org/10.3390/cells8020105
APA Style
Zella, M. A. S., Metzdorf, J., Ostendorf, F., Maass, F., Muhlack, S., Gold, R., Haghikia, A., & Tönges, L.
(2019). Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson’s Disease. Cells, 8(2), 105.
https://doi.org/10.3390/cells8020105